The main factors leading to the development of anaemia in this group of patients are blood loss, shortened red cell life span, vitamin deficiency, the ‘uremic milieu’, iron and erythropoietin (EPO) deficiency as well as reduced ability to bind Fe, inflammation and hyperparathyroidism [13]. The gene discussed is EPO; the disease is hyperinsulinemic hypoglycemia, familial, 4.